Anti-Viral Activity of Bioactive Molecules of Silymarin against COVID-19 via In Silico Studies

The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection drove the global coronavirus disease 2019 (COVID-19) pandemic, causing a huge loss of human life and a negative impact on economic development. It is an urgent necessity to explore potential drugs against viruses, such as SAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chunye, Sui, Yuxiang, Liu, Shuai, Yang, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610370/
https://www.ncbi.nlm.nih.gov/pubmed/37895950
http://dx.doi.org/10.3390/ph16101479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610370/
https://www.ncbi.nlm.nih.gov/pubmed/37895950
http://dx.doi.org/10.3390/ph16101479

Ejemplares similares